Serum haloperidol levels and clinical response in chronic, treatment-resistant schizophrenic patients

Journal of Psychopharmacology

Volumn 2, Issue 2, 1988, Pages 94-103

  Browne, F W A ^a   Cooper, S J ^b   Wilson, R ^b   King, D J ^b  

^a Holywell Hospital   (United Kingdom)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HALOPERIDOL;

ADULT; BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; ORAL DRUG ADMINISTRATION; RELAPSE; SCHIZOPHRENIA;

EID: 0023771688     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/026988118800200204     Document Type: Article

References (38)

1. Andrews P., Hall J.N., Snaith R.P. 1976 A controlled trial of phenothiazine withdrawal in chronic schizophrenic patients. Brit J Psychiat 128: 451-455
2. Åsberg M., Montgomery S.A., Perris C., Schalling D., Sedvall G. 1978 A comprehensive psychopathological rating scale. Acta Psychiat Scand (Supplement) 271: 5-27
3. Ayd F. 1972 Haloperidol: fifteen years of clinical experience. Dis Nerv Sys 33: 459-469
4. Bjørndal N., Bjerre M., Gerlach J., Kristjansen P., Magelund G., Oestrich I.H., Waehrens J. 1980 High dosage haloperidol therapy in chronic schizophrenic patients: a double-blind study of clinical response, side-effects, serum haloperidol and serum prolactin. Psychopharmacology 67: 17-23
5. Bollini P., Andream A., Colombo F., Bellantuono C., Beretta P., Arduim A., Galli T., Tognom G. 1984 High-dose neuroleptics: uncontrolled clinical practice confirms controlled clinical trials. Brit J Psychiat 144: 25-27
6. Cohen B.M., Baldessarini R.J. 1981 Haloperidol levels and clinical response. Amer J Psychiat 138: 1513-1514
7. Donlon P.T., Hopkm J.T., Tupm J.P., Wicks J.J., Wahba M., Meadow A. 1980 Haloperidol for acute schizophrenic patients. Arch Gen Psychiat 37: 691-695
8. Ericksen S., Hurt S.W., Chang S. 1978 Haloperidol dose, plasma levels and clinical response: a double-blind study. Psychopharmacol Bull 14: 15-16
9. Extein I., Pottash A L C, Gold M.S. 1983 Therapeutic window for plasma haloperidol in acute schizophrenic psychosis. Lancet 1: 1048-1049
10. Feighner J.P., Robins E., Guze S.B., Woodruff R.A., Winokur G., Munoz R. 1972 Diagnostic criteria for use in psychiatric research. Arch Gen Psychiat 26: 57-63
11. Flaherty J.A., Lahmeyer H.W. 1978 Laryngeal-pharyngeal dystonia as a possible cause of asphyxia with haloperidol treatment. Amer J Psychiat 135: 1414-1415
12. Forsman A.O. 1976 Individual variability in response to haloperidol. Proc Roy Soc Med 69(Supplement 1): 9-13
13. Fottrell E., Sheikh M., Kothari R., Sayed I. 1976 Long-stay patients with long-stay drugs. A case for review; a cause for concern. Lancet 1: 81-82
14. Hollister L.E., Kim D.Y. 1982 Intensive treatment with haloperidol of treatment-resistant chronic schizophrenic patients Amer J Psychiat 139: 1466-1468
15. Johnstone E.C., Crow T.J., Frith C.D., Carney M W P, Price J.S. 1978 Mechanism of the antipsychotic effect in the treatment of acute schizophrenia. Lancet 1: 848-851
16. Ketai R., Matthews J., Mozdzen JJ 1979 Sudden death in a patient taking haloperidol. Amer J Psychiat 136: 112-113
17. Krawiecka M., Goldberg D., Vaughan M. 1977 A standardized psychiatric assessment scale for rating chronic psychotic patients. Acta Psychiat Scand 55: 299-308
18. Kucharski L.T., Alexander P., Tune L., Coyle J. 1984 Serum neuroleptic concentrations and clinical response: a radioreceptor assay investigation of acutely psychotic patients Psychopharmacology 82: 194-198
19. Letemendia F J J, Harris A.D. 1967 Chlorpromazine and the untreated chronic schizophrenic: a long-term trial. Brit J Psychiat 113: 950-958
20. McCreadie R.G., MacDonald I.M. 1977 High dosage haloperidol in chronic schizophrenia. Brit J Psychiat 131: 310-316
21. Magliozzi J.R., Hollister L.E., Arnold K.V., Earle G.M. 1981 Relationship of serum haloperidol levels to clinical response in schizophrenic patients. Amer J Psychiat 138: 365-367
22. Mavroidis M.L., Kanter D.R., Hirschowitz J., Garver D.L. 1983 Clinical response and plasma haloperidol levels in schizophrenia. Psychopharmacology 81: 354-356
23. Mendlewicz J., Linkowski P., Alexandre J., Schoutens A. 1981 Haloperidol plasma levels and clinical response in schizophrenia. In Clinical pharmacology in psychiatry (eds Usdin E, Dahl S G, Gram L F, Lingjaerde O) Macmillan Publishers Ltd, London, pp. 233-237.
24. Modestin J., Krapf R., Boker W. 1981 A fatality during haloperidol treatment: mechanisms of sudden death. Amer J Psychiat 138: 1616-1617
25. Modestin J., Toffler G., Pia M., Greub E. 1983 Haloperidol in acute schizophrenia in-patients. A double-blind comparison of two dosage regimens. Pharmacopsychiatry 16: 121-126
26. Montgomery S.A., Montgomery D.B. 1980 Measurement of change in psychiatric illness: new obsessional, schizophrenic and depression scales. Postgrad Med J 56 (Supplement 1): 50-52
27. Potkin S.G., Shen Y., Zhou D., Pardes H., Shu L., Phelps B., Poland R. 1985 Does a therapeutic window for plasma haloperidol exist?: preliminary Chinese data Psychopharmacol Bull 21: 59-61
28. Psaras M., Zissis N.P., Mouzakis D., Lyketsos G. 1980 Mobilization of refractory chronic schizophrenics with haloperidol. Int Pharmacopsychiat 15: 180-185
29. van Putten T., May P R A, Jenden D.J. 1981 Does a plasma level of chlorpromazine help? Psychol Med 11: 729-734
30. Rao V A R, Bishop M., Coppen A. 1980 Clinical state, plasma levels of haloperidol and prolactin: a correlation study in chronic schizophrenia. Brit J Psychiat 137: 518-521
31. Rimon R., Averbuch I., Rozick P., Fijman-Danilovich L., Kara T., Dasberg H., Ebstein R.P., Belmaker R.H. 1981 Serum and CSF levels of haloperidol by radioimmunoassay and radioreceptor assay during high-dose therapy of resistant schizophrenic patients. Psychopharmacology 73: 197-199
32. Schaffer C.B., Shahid A., Javaid J.I., Dysken M.W., Davis J.M. 1982 Bioavailability of intramuscular versus oral haloperidol in schizophrenic patients. Journal of Clinical Psychopharmacology 2: 274-277
33. Schulz S.C., Butterfield L., Garicano M., Narasimhachari N., Friedel R.O. 1984 Beyond the therapeutic window: a case presentation. Journal of Clinical Pharmacology 45: 223-225
34. Silverstone T., Cookson J., Ball R., Chin C.N., Jacobs D., Lader S., Gould S. 1984 The relationship of dopamine receptor blockade to clinical response in schizophrenic patients treated with pimozide or haloperidol. J Psychiat Res 18: 255-268
35. Smith R.C., Crayton J., Dekirmenjian H., Klass D., Davis J.M. 1979 Blood levels of neuroleptic drugs in non-responding chronic schizophrenic patients. Arch Gen Psychiat 36: 579-584
36. Smith R.C., Vroulis G., Shvartsburd A., Allen R., Lewis N., Schoolar J.C., Chojancki M., Johnson R. 1982 RBC and plasma levels of haloperidol and clinical response in schizophrenia. Amer J Psychiat 139: 1054-1056
37. Smith R.C., Baumgartner R., Shvartsburd A., Ravichandran G.K., Vroulis G., Mauldin M. 1985 Comparative efficacy of red cell and plasma haloperidol as predictors of clinical response in schizophrenia. Psychopharmacology 85: 449-455
38. Zarifian E., Scatton B., Bianchetti G., Cuche H., Loo H., Morselli P.L. 1982 High doses of haloperidol in schizophrenia. A clinical, biochemical and pharmacokinetic study. Arch Gen Psychiat 39: 212-215